Results 51 to 60 of about 430,871 (256)

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Plant production and immunogenic characterisation of Human papillomavirus chimaeric vaccines [PDF]

, 2011
Includes abstract.Includes bibliographical references (leaves 153-175).Cervical cancer is primarily caused by infection with Human papillomavirus (HPV) and is a global concern, particularly in developing countries which contain ~80% of the cervical ...
Pineo, Catherine
core   +1 more source

Effectiveness of HPV vaccine as part of national immunization program for preventing HPV infection in Thai schoolgirls after seven years post-vaccination

Human Vaccines & Immunotherapeutics
Thailand introduced a two-dose regimen of bivalent HPV vaccines for Grade 5 schoolgirls, approximately 11 years old, initially piloted in Ayutthaya province in 2014, and nationwide under the National Immunization Program (NIP) in 2017.
Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Ratchadawan Aeemchinda, Wichan Bhunyakitikorn, Thanawadee Thantithaveewat, Sunanta Seetho, Darunee Phosri, Naiyana Netthip, Nungruthai Suntronwong, Nasamon Wanlapakorn, Yong Poovorawan   +10 more
doaj   +1 more source

The influence of affect on HPV vaccine decision making in an HPV vaccine naïve college student population

Preventive Medicine Reports, 2020
The HPV vaccine is recommended for all adolescents starting at age 11, but coverage is low, especially in the young adult population. The CDC is prioritizing catch-up vaccination and has expanded recommendations for all young adults to age 26.
Lynne B. Klasko-Foster, Sarahmona Przybyla, Heather Orom, Elizabeth Gage-Bouchard, Marc T. Kiviniemi   +4 more
doaj   +1 more source

Community Head and Neck Cancer Knowledge, Engagement, Research, and Screening (CHECKERS): Protocol for a Community‐Engaged Approach to Head and Neck Cancer Prevention

Cancer Nexus, EarlyView.
ABSTRACT Introduction Unequal access to care is associated with disparities in prevention, early detection, and outcomes of head and neck cancer (HNC), especially in underserved populations. Community‐engaged research (CEnR) aims to build capacity for community members to address health inequity via bidirectional partnerships with healthcare ...
Nicholas A. Frisco, Vincent M. D'Anniballe, May Z. Gao, Melissa White, Leda Scearce, Dina K. Abouelella, Laura J. Fish, Patrick Warutere, Julius Muchangi, Pauline Mureithi, Trinitia Y. Cannon, Nosayaba Osazuwa‐Peters   +11 more
wiley   +1 more source

The impact of vaccine access difficulties on HPV vaccine intention and uptake among female university students in China

International Journal for Equity in Health
Background Ensuring vaccine access is a prerequisite for promoting human papilloma virus (HPV) vaccination. Although HPV vaccination efforts in China have primarily focused on young females, little research has examined the difficulties they face in ...
Weiyi Wang
doaj   +1 more source

Human papillomavirus vaccine administration behaviors and influences among Arizona pharmacists and pharmacy interns

Human Vaccines & Immunotherapeutics, 2021
This study assessed 27 Arizona community pharmacists’ and pharmacy interns’ human papillomavirus (HPV) vaccine administration behaviors and influences.
Alexis Koskan, Maricarmen Vizcaino, Stephanie A. Brennhofer, Chong D. Lee, Anthony J. Roberto   +4 more
doaj   +1 more source

Genetic variants of EcPV2 E6 and E7 in equine genital and oronasal squamous cell carcinoma

Equine Veterinary Journal, EarlyView.
Abstract Background Since its discovery in 2008, equine papillomavirus type 2 (EcPV2) has been detected in up to 100% of equine genital and up to 40% of equine oronasal squamous cell carcinomas (SCCs). Preliminary sequence data point to the existence of EcPV2 E6 and E7 oncogene variants compared to the British reference sequence from 2008.
Maya Jenner, Sabine Brandt
wiley   +1 more source

Acceptability of HPV Vaccine for Males and Preferences for Future Education Programs Among Appalachian Residents

American Journal of Men's Health, 2014
Appalachia is a geographic region with several disparities related to human papillomavirus (HPV) infection, yet little is known about acceptability of HPV vaccine for males among Appalachian residents. HPV vaccine acceptability and preferences for future
Paul L. Reiter PhD, Benjamin R. Oldach MPH, Katherine E. Randle MPH, Mira L. Katz PhD   +3 more
doaj   +1 more source

PREDITORS AND ACCEPTABILITY OF HUMAN PAPILLOMA VIRUS VACCINE UPTAKE AMONG SENIOR SECONDARY SCHOOL STUDENTS IN ILE-IFE

Sanamed, 2019
Introduction: Cervical cancer is the second most common cancer in women worldwide and in Nigeria. Human papilloma virus (HPV), has been implicated as the causative agent of cervical cancer. The fact that HPV vaccination can prevent the occurrence of this
Fehintola O Funmito, Fehintola O Akintunde, Ogundele A Olorunfemi, Adegbenro A Caleb, Olowookere A Samuel, Afolabi T Olusegun   +5 more
doaj   +1 more source